Jung Yoon Suk, Park Dong Il, Kim Won Hee, Eun Chang Soo, Park Soo-Kyung, Ko Bong Min, Seo Geom Seog, Cha Jae Myung, Park Jae Jun, Kim Kyeong Ok, Moon Chang Mo, Jung Yunho, Kim Eun Soo, Jeon Seong Ran, Lee Chang Kyun
Department of Internal Medicine, Kangbuk Samsung Hospital, School of Medicine, Sungkyunkwan University, 108, Pyung-Dong, Jongro-Ku, Seoul, 110-746, Korea.
Digestive Disease Center, CHA Bundang Medical Center, CHA University, 59, Yatap-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 463-712, Korea.
Dig Dis Sci. 2016 Jun;61(6):1661-8. doi: 10.1007/s10620-016-4038-0. Epub 2016 Jan 25.
Data regarding outcomes for patients with multiple findings for high-risk adenomas are scarce.
To compare the risk for colorectal neoplasm (CRN) recurrence according to the number of high-risk findings.
This was a retrospective and multicenter study. Patients who had one or more high-risk adenomas at the index colonoscopy and underwent follow-up colonoscopy 2.5 or more years after the index colonoscopy were included. The number of high-risk findings was defined as follows: number of adenomas larger than 1 cm + number of adenomas with HGD + number of adenomas with a villous component + existence (counted as 1) or nonexistence (counted as 0) of three or more adenomas.
A total of 1646 patients were included, and the mean duration between index and follow-up colonoscopy was approximately 4 years. The cumulative incidence rate of recurrent advanced CRN in patients with three or more high-risk findings was higher than that in patients with one or two high-risk findings (p < 0.001). However, the difference in 3-year cumulative incidence rates of recurrent advanced CRN between the two groups was not great, although it was statistically significant (4.8 vs. 2.3 %, p = 0.039).
A 3-year surveillance interval for patients with multiple high-risk findings, regardless of the number of high-risk findings, appears reasonable.
关于具有多种高危腺瘤发现的患者结局的数据稀缺。
根据高危发现的数量比较结直肠肿瘤(CRN)复发风险。
这是一项回顾性多中心研究。纳入在首次结肠镜检查时发现一个或多个高危腺瘤且在首次结肠镜检查后2.5年或更长时间接受随访结肠镜检查的患者。高危发现的数量定义如下:直径大于1 cm的腺瘤数量 + 高级别上皮内瘤变(HGD)腺瘤数量 + 具有绒毛成分的腺瘤数量 + 三个或更多腺瘤的存在(计为1)或不存在(计为0)。
共纳入1646例患者,首次结肠镜检查与随访结肠镜检查之间的平均时长约为4年。具有三个或更多高危发现的患者中复发性进展期CRN的累积发病率高于具有一个或两个高危发现的患者(p < 0.001)。然而,两组之间复发性进展期CRN的3年累积发病率差异不大,尽管具有统计学意义(4.8% 对2.3%,p = 0.039)。
对于具有多种高危发现的患者,无论高危发现的数量如何,3年的监测间隔似乎是合理的。